CARMA3 mediates lysophosphatidic acid-stimulated cytokine secretion by bronchial epithelial cells.
about
The paracaspase MALT1: biological function and potential for therapeutic inhibitionOverexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progressionLow-concentration ozone reacts with plasmalogen glycerophosphoethanolamine lipids in lung surfactant.Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosomeNF-κB signaling pathways regulated by CARMA family of scaffold proteins.CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation.Lpa2 is a negative regulator of both dendritic cell activation and murine models of allergic lung inflammation.The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injuryNovel Inhibitory Effect of a Lysophosphatidic Acid 2 Agonist on Allergen-Driven Airway Inflammation.Polyunsaturated lysophosphatidic acid as a potential asthma biomarker.The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation.From MALT lymphoma to the CBM signalosome: three decades of discovery.Function and mechanisms of TSLP/TSLPR complex in asthma and COPD.The airway epithelium in asthma.Thymic stromal lymphopoietin: a central regulator of allergic asthma.MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10.Allergic to autotaxin. A new role for lysophospholipase d and lysophosphatidic Acid in asthma?CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis
P2860
Q26778357-05750508-BF34-4E5C-B74A-71408ACBC5EAQ28483701-02D2D73D-C2D0-461C-8CD9-7B85E2F8019BQ33596290-3AFFC16C-0D53-4BB8-9026-8A76351C2C10Q34438768-4D3E1DB0-2BE2-4E36-9141-7B707B44E1A3Q35347919-E6060E80-853D-41C1-B551-C9026E0DB2E3Q35809995-DAE641F9-66FF-4BC9-ABDB-B491A8E812ABQ35883942-FA8EB463-43B6-42F8-A697-BC67B0B7C6CEQ35889195-019C05A5-D842-4650-9C98-3FE8F8DFF133Q36765897-1141E651-980D-4A4D-9C44-8A0D5901E653Q36939914-B4A9B286-6B32-498F-AC3E-4F91DDF1E2D9Q37527792-8154C2E0-CDB9-4E9A-9911-0EF7FE04EAAEQ37900457-629C965D-8955-46B6-A897-DF96DA54CCC4Q37968330-57996ACC-4F7B-48D9-98BE-5073FDFAF51DQ38007828-6FD71072-D618-464B-B2E1-B07F71081289Q38220362-76BD299C-2962-475A-A011-60D00BAD86EFQ39686103-ACBF5D2C-AF14-48CC-AB02-702AB4A3EEFAQ42909461-FC7E9076-0643-4277-8C37-AB5D07B9C62DQ58777266-BFC4D646-EDA8-4B28-8A62-5E45A55A2274
P2860
CARMA3 mediates lysophosphatidic acid-stimulated cytokine secretion by bronchial epithelial cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
CARMA3 mediates lysophosphatid ...... by bronchial epithelial cells.
@en
type
label
CARMA3 mediates lysophosphatid ...... by bronchial epithelial cells.
@en
prefLabel
CARMA3 mediates lysophosphatid ...... by bronchial epithelial cells.
@en
P2093
P2860
P356
P1476
CARMA3 mediates lysophosphatid ...... by bronchial epithelial cells
@en
P2093
Aimee L Landry
Barry P Sandall
Joe C Adams
Kelley A Wittbold
Merran C Derby
Ramnik J Xavier
Zhifang Cao
P2860
P304
P356
10.1165/RCMB.2008-0129OC
P577
2008-08-28T00:00:00Z